Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
TAZ, a Transcriptional Modulator of Mesenchymal Stem Cell Differentiation
Jeong-Ho Hong,1Eun Sook Hwang,3Michael T. McManus,1Adam Amsterdam,1Yu Tian,4Ralitsa Kalmukova,1Elisabetta Mueller,5Thomas Benjamin,4Bruce M. Spiegelman,5Phillip A. Sharp,1Nancy Hopkins,1Michael B. Yaffe1,2*
Mesenchymal stem cells (MSCs) are a pluripotent cell type thatcan differentiate into several distinct lineages. Two key transcriptionfactors, Runx2 and peroxisome proliferatoractivated receptor (PPAR), drive MSCs to differentiate into either osteoblastsor adipocytes, respectively. How these two transcription factorsare regulated in order to specify these alternate cell fatesremains a pivotal question. Here we report that a 14-3-3bindingprotein, TAZ (transcriptional coactivator with PDZ-binding motif),coactivates Runx2-dependent gene transcription while repressingPPAR-dependent gene transcription. By modulating TAZ expressionin model cell lines, mouse embryonic fibroblasts, and primaryMSCs in culture and in zebrafish in vivo, we observed alterationsin osteogenic versus adipogenic potential. These results indicatethat TAZ functions as a molecular rheostat that modulates MSCdifferentiation.
1 Center for Cancer Research, Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, E18-580, Cambridge, MA 02139, USA. 2 Division of Biological Engineering, Massachusetts Institute of Technology, 77 Massachusetts Avenue, E18-580, Cambridge, MA 02139, USA. 3 Department of Immunology and Infectious Diseases, Harvard School of Public Health, Harvard Medical School, Boston, MA 02115, USA. 4 Department of Pathology, Harvard Medical School, 77 Louis Pasteur Avenue, Boston, MA 02115, USA. 5 Dana-Farber Cancer Institute and the Department of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
* To whom correspondence should be addressed. E-mail: myaffe{at}mit.edu
Regulation of adipogenic differentiation by LAR tyrosine phosphatase in human mesenchymal stem cells and 3T3-L1 preadipocytes.
W.-K. Kim, H. Jung, D.-H. Kim, E.-Y. Kim, J.-W. Chung, Y.-S. Cho, S.-G. Park, B.-C. Park, Y. Ko, K.-H. Bae, et al. (2009)
J. Cell Sci.
122, 4160-4167
|Abstract »|Full Text »|PDF »
The Hippo Tumor Suppressor Pathway: A Brainstorming Workshop.
G. Blandino, Y. Shaul, S. Strano, M. Sudol, and M. Yaffe (2009)
Science Signaling
2, mr6
|Abstract »|Full Text »|PDF »
Lessons in Signaling and Tumorigenesis from Polyomavirus Middle T Antigen.
M. M. Fluck and B. S. Schaffhausen (2009)
Microbiol. Mol. Biol. Rev.
73, 542-563
|Abstract »|Full Text »|PDF »
Transcriptional Coactivator with PDZ-binding Motif Is Essential for Normal Alveolarization in Mice.
A. Mitani, T. Nagase, K. Fukuchi, H. Aburatani, R. Makita, and H. Kurihara (2009)
Am. J. Respir. Crit. Care Med.
180, 326-338
|Abstract »|Full Text »|PDF »
TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation.
S. W. Chan, C. J. Lim, L. S. Loo, Y. F. Chong, C. Huang, and W. Hong (2009)
J. Biol. Chem.
284, 14347-14358
|Abstract »|Full Text »|PDF »
Glis3 Is Associated with Primary Cilia and Wwtr1/TAZ and Implicated in Polycystic Kidney Disease.
H. S. Kang, J. Y. Beak, Y.-S. Kim, R. Herbert, and A. M. Jetten (2009)
Mol. Cell. Biol.
29, 2556-2569
|Abstract »|Full Text »|PDF »
TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal Transition.
H. Zhang, C.-Y. Liu, Z.-Y. Zha, B. Zhao, J. Yao, S. Zhao, Y. Xiong, Q.-Y. Lei, and K.-L. Guan (2009)
J. Biol. Chem.
284, 13355-13362
|Abstract »|Full Text »|PDF »
IKK{beta} and the anti-adipogenic effect of platelet-derived growth factor in human abdominal subcutaneous preadipocytes.
CHIP promotes Runx2 degradation and negatively regulates osteoblast differentiation.
X. Li, M. Huang, H. Zheng, Y. Wang, F. Ren, Y. Shang, Y. Zhai, D. M. Irwin, Y. Shi, D. Chen, et al. (2008)
J. Cell Biol.
181, 959-972
|Abstract »|Full Text »|PDF »
The WWOX Tumor Suppressor Is Essential for Postnatal Survival and Normal Bone Metabolism.
R. I. Aqeilan, M. Q. Hassan, A. de Bruin, J. P. Hagan, S. Volinia, T. Palumbo, S. Hussain, S.-H. Lee, T. Gaur, G. S. Stein, et al. (2008)
J. Biol. Chem.
283, 21629-21639
|Abstract »|Full Text »|PDF »
Reciprocal Relation between Marrow Adiposity and the Amount of Bone in the Axial and Appendicular Skeleton of Young Adults.
N. Di Iorgi, M. Rosol, S. D. Mittelman, and V. Gilsanz (2008)
J. Clin. Endocrinol. Metab.
93, 2281-2286
|Abstract »|Full Text »|PDF »
A Role for TAZ in Migration, Invasion, and Tumorigenesis of Breast Cancer Cells.
S. W. Chan, C. J. Lim, K. Guo, C. P. Ng, I. Lee, W. Hunziker, Q. Zeng, and W. Hong (2008)
Cancer Res.
68, 2592-2598
|Abstract »|Full Text »|PDF »
TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo Pathway.
Q.-Y. Lei, H. Zhang, B. Zhao, Z.-Y. Zha, F. Bai, X.-H. Pei, S. Zhao, Y. Xiong, and K.-L. Guan (2008)
Mol. Cell. Biol.
28, 2426-2436
|Abstract »|Full Text »|PDF »
The Adipogenic Acetyltransferase Tip60 Targets Activation Function 1 of Peroxisome Proliferator-Activated Receptor {gamma}.
O. van Beekum, A. B. Brenkman, L. Grontved, N. Hamers, N. J. F. van den Broek, R. Berger, S. Mandrup, and E. Kalkhoven (2008)
Endocrinology
149, 1840-1849
|Abstract »|Full Text »|PDF »
Runt-Related Transcription Factor 2 (RUNX2) and RUNX2-Related Osteogenic Genes Are Down-Regulated throughout Osteogenesis in Type 1 Diabetes Mellitus.
J. L. Fowlkes, R. C. Bunn, L. Liu, E. C. Wahl, H. N. Coleman, G. E. Cockrell, D. S. Perrien, C. K. Lumpkin Jr., and K. M. Thrailkill (2008)
Endocrinology
149, 1697-1704
|Abstract »|Full Text »|PDF »
Age-Related Changes in Bone Morphology Are Accelerated in Group VIA Phospholipase A2 (iPLA2{beta})-Null Mice.
S. Ramanadham, K. E. Yarasheski, M. J. Silva, M. Wohltmann, D. V. Novack, B. Christiansen, X. Tu, S. Zhang, X. Lei, and J. Turk (2008)
Am. J. Pathol.
172, 868-881
|Abstract »|Full Text »|PDF »
Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ.
R. Makita, Y. Uchijima, K. Nishiyama, T. Amano, Q. Chen, T. Takeuchi, A. Mitani, T. Nagase, Y. Yatomi, H. Aburatani, et al. (2008)
Am J Physiol Renal Physiol
294, F542-F553
|Abstract »|Full Text »|PDF »
Regulation of Mesenchymal Stem Cell Osteogenic Differentiation by Glucocorticoid-induced Leucine Zipper (GILZ).
Runx2 Represses Myocardin-Mediated Differentiation and Facilitates Osteogenic Conversion of Vascular Smooth Muscle Cells.
T. Tanaka, H. Sato, H. Doi, C. A. Yoshida, T. Shimizu, H. Matsui, M. Yamazaki, H. Akiyama, K. Kawai-Kowase, T. Iso, et al. (2008)
Mol. Cell. Biol.
28, 1147-1160
|Abstract »|Full Text »|PDF »
Homodimerization of Ror2 Tyrosine Kinase Receptor Induces 14-3-3{beta} Phosphorylation and Promotes Osteoblast Differentiation and Bone Formation.
Y. Liu, J. F. Ross, P. V. N. Bodine, and J. Billiard (2007)
Mol. Endocrinol.
21, 3050-3061
|Abstract »|Full Text »|PDF »
TAZ Promotes PC2 Degradation through a SCF{beta}-Trcp E3 Ligase Complex.
Y. Tian, R. Kolb, J.-H. Hong, J. Carroll, D. Li, J. You, R. Bronson, M. B. Yaffe, J. Zhou, and T. Benjamin (2007)
Mol. Cell. Biol.
27, 6383-6395
|Abstract »|Full Text »|PDF »
Adipocyte differentiation induced using nonspecific siRNA controls in cultured human mesenchymal stem cells.
Y. Xu, S.-H. Mirmalek-Sani, F. Lin, J. Zhang, and R. O.C. Oreffo (2007)
RNA
13, 1179-1183
|Abstract »|Full Text »|PDF »
Senescence-unrelated impediment of osteogenesis from Flk1+ bone marrow mesenchymal stem cells induced by total body irradiation and its contribution to long-term bone and hematopoietic injury.
J. Ma, M. Shi, J. Li, B. Chen, H. Wang, B. Li, J. Hu, Y. Cao, B. Fang, and R. C. Zhao (2007)
Haematologica
92, 889-896
|Abstract »|Full Text »|PDF »
A high-throughput siRNA library screen identifies osteogenic suppressors in human mesenchymal stem cells.
Wnt Signaling Stimulates Osteoblastogenesis of Mesenchymal Precursors by Suppressing CCAAT/Enhancer-binding Protein {alpha} and Peroxisome Proliferator-activated Receptor {gamma}.
S. Kang, C. N. Bennett, I. Gerin, L. A. Rapp, K. D. Hankenson, and O. A. MacDougald (2007)
J. Biol. Chem.
282, 14515-14524
|Abstract »|Full Text »|PDF »
dlk1/FA1 Regulates the Function of Human Bone Marrow Mesenchymal Stem Cells by Modulating Gene Expression of Pro-inflammatory Cytokines and Immune Response-related Factors.
B. M. Abdallah, P. Boissy, Q. Tan, J. Dahlgaard, G. A. Traustadottir, K. Kupisiewicz, J. Laborda, J.-M. Delaisse, and M. Kassem (2007)
J. Biol. Chem.
282, 7339-7351
|Abstract »|Full Text »|PDF »
Activation of Peroxisome Proliferator-Activated Receptor {gamma} (PPAR{gamma}) by Rosiglitazone Suppresses Components of the Insulin-Like Growth Factor Regulatory System in Vitro and in Vivo.
B. Lecka-Czernik, C. Ackert-Bicknell, M. L. Adamo, V. Marmolejos, G. A. Churchill, K. R. Shockley, I. R. Reid, A. Grey, and C. J. Rosen (2007)
Endocrinology
148, 903-911
|Abstract »|Full Text »|PDF »
Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1.
Z. Hossain, S. M. Ali, H. L. Ko, J. Xu, C. P. Ng, K. Guo, Z. Qi, S. Ponniah, W. Hong, and W. Hunziker (2007)
PNAS
104, 1631-1636
|Abstract »|Full Text »|PDF »
Fat Mass Is Not Beneficial to Bone in Adolescents and Young Adults.
A. Janicka, T. A. L. Wren, M. M. Sanchez, F. Dorey, P. S. Kim, S. D. Mittelman, and V. Gilsanz (2007)
J. Clin. Endocrinol. Metab.
92, 143-147
|Abstract »|Full Text »|PDF »
International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors.
L. Michalik, J. Auwerx, J. P. Berger, V. K. Chatterjee, C. K. Glass, F. J. Gonzalez, P. A. Grimaldi, T. Kadowaki, M. A. Lazar, S. O'Rahilly, et al. (2006)
Pharmacol. Rev.
58, 726-741
|Abstract »|Full Text »|PDF »
C.-L. Tso, P. Shintaku, J. Chen, Q. Liu, J. Liu, Z. Chen, K. Yoshimoto, P. S. Mischel, T. F. Cloughesy, L. M. Liau, et al. (2006)
Mol. Cancer Res.
4, 607-619
|Abstract »|Full Text »|PDF »
Osteogenic differentiation of mouse adipose-derived adult stromal cells requires retinoic acid and bone morphogenetic protein receptor type IB signaling.
D. C. Wan, Y.-Y. Shi, R. P. Nacamuli, N. Quarto, K. M. Lyons, and M. T. Longaker (2006)
PNAS
103, 12335-12340
|Abstract »|Full Text »|PDF »
Role of Adipose Tissue as an Inflammatory Organ in Human Diseases.
A. Schaffler, U. Muller-Ladner, J. Scholmerich, and C. Buchler (2006)
Endocr. Rev.
27, 449-467
|Abstract »|Full Text »|PDF »
Defects in Yolk Sac Vasculogenesis, Chorioallantoic Fusion, and Embryonic Axis Elongation in Mice with Targeted Disruption of Yap65.
E. M. Morin-Kensicki, B. N. Boone, M. Howell, J. R. Stonebraker, J. Teed, J. G. Alb, T. R. Magnuson, W. O'Neal, and S. L. Milgram (2006)
Mol. Cell. Biol.
26, 77-87
|Abstract »|Full Text »|PDF »
A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome.
M. Murakami, M. Nakagawa, E. N. Olson, and O. Nakagawa (2005)
PNAS
102, 18034-18039
|Abstract »|Full Text »|PDF »
The Family of Osteoblast Transcription Factors is Growing.
G. A. Rodan and A. R. Rodan (2005)
IBMS BoneKEy
2, 12-15
|Full Text »|PDF »